PINK1 and chronic kidney disease: Pioglitazone can repair mitochondrial dysfunction induced by uraemia by upregulating PINK1 expression, inhibiting mitochondrial fusion and promoting mitophagy, thus reducing the degree of damage associated with chronic kidney diseases (CKDs) [29].